MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 126 filers reported holding MACROGENICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $55,710 | -12.6% | 11,955 | +0.3% | 0.00% | – |
Q2 2023 | $63,756 | -21.7% | 11,917 | +4.9% | 0.00% | – |
Q1 2023 | $81,423 | -5.5% | 11,356 | -11.6% | 0.00% | – |
Q4 2022 | $86,163 | +110.2% | 12,841 | +8.7% | 0.00% | – |
Q3 2022 | $41,000 | +20.6% | 11,815 | +2.3% | 0.00% | – |
Q2 2022 | $34,000 | -78.2% | 11,549 | -34.4% | 0.00% | – |
Q1 2022 | $156,000 | -55.2% | 17,604 | -18.9% | 0.00% | -100.0% |
Q4 2021 | $348,000 | -19.8% | 21,718 | +4.7% | 0.00% | 0.0% |
Q3 2021 | $434,000 | -38.1% | 20,746 | -20.5% | 0.00% | -50.0% |
Q2 2021 | $701,000 | -2.0% | 26,091 | +16.3% | 0.00% | 0.0% |
Q1 2021 | $715,000 | +50.2% | 22,442 | +7.8% | 0.00% | 0.0% |
Q4 2020 | $476,000 | +24.3% | 20,823 | +37.0% | 0.00% | 0.0% |
Q3 2020 | $383,000 | -4.5% | 15,194 | +5.9% | 0.00% | 0.0% |
Q2 2020 | $401,000 | +116.8% | 14,351 | -15.8% | 0.00% | +100.0% |
Q4 2019 | $185,000 | -22.3% | 17,039 | -8.7% | 0.00% | 0.0% |
Q3 2019 | $238,000 | -23.7% | 18,665 | +1.5% | 0.00% | -50.0% |
Q2 2019 | $312,000 | -16.8% | 18,392 | -11.7% | 0.00% | 0.0% |
Q1 2019 | $375,000 | +60.3% | 20,835 | +12.9% | 0.00% | 0.0% |
Q4 2018 | $234,000 | -50.4% | 18,455 | -16.2% | 0.00% | -33.3% |
Q3 2018 | $472,000 | -0.2% | 22,018 | -3.8% | 0.00% | 0.0% |
Q2 2018 | $473,000 | -12.2% | 22,899 | +7.0% | 0.00% | -25.0% |
Q1 2018 | $539,000 | +14.0% | 21,404 | -13.9% | 0.00% | +33.3% |
Q4 2017 | $473,000 | +11.0% | 24,870 | +7.9% | 0.00% | -25.0% |
Q3 2017 | $426,000 | +16.4% | 23,056 | +10.3% | 0.00% | 0.0% |
Q2 2017 | $366,000 | -11.8% | 20,911 | -6.4% | 0.00% | 0.0% |
Q1 2017 | $415,000 | -27.8% | 22,337 | -20.6% | 0.00% | -33.3% |
Q4 2016 | $575,000 | -23.2% | 28,136 | +12.3% | 0.01% | -40.0% |
Q3 2016 | $749,000 | -6.3% | 25,044 | -15.4% | 0.01% | 0.0% |
Q2 2016 | $799,000 | +44.7% | 29,614 | +0.7% | 0.01% | +25.0% |
Q1 2016 | $552,000 | -44.6% | 29,414 | -8.6% | 0.01% | -33.3% |
Q4 2015 | $997,000 | +60.0% | 32,179 | +10.7% | 0.01% | +33.3% |
Q3 2015 | $623,000 | -40.4% | 29,081 | +5.5% | 0.01% | -35.7% |
Q2 2015 | $1,046,000 | +26.9% | 27,558 | +5.0% | 0.01% | +40.0% |
Q1 2015 | $824,000 | +3.5% | 26,254 | +15.7% | 0.01% | +11.1% |
Q4 2014 | $796,000 | +275.5% | 22,696 | +133.1% | 0.01% | +200.0% |
Q2 2014 | $212,000 | – | 9,736 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 707,978 | $21,176,000 | 2.34% |
Opaleye Management Inc. | 145,000 | $4,337,000 | 2.27% |
TIGER MANAGEMENT L.L.C. | 266,067 | $7,958,000 | 1.88% |
TANAKA CAPITAL MANAGEMENT INC | 26,170 | $783,000 | 1.88% |
BB BIOTECH AG | 1,455,000 | $43,519,000 | 1.53% |
Eventide Asset Management | 725,800 | $21,709,000 | 1.32% |
DAFNA Capital Management LLC | 54,200 | $1,621,000 | 1.13% |
Spark Investment Management LLC | 390,600 | $11,682,000 | 0.95% |
Private Capital Advisors, Inc. | 72,500 | $2,168,000 | 0.77% |
Rhenman & Partners Asset Management AB | 140,000 | $4,187,400,000 | 0.66% |